Cell differentiation and dominant signaling pathway signatures in the molecular classification of human breast cancer cell lines

Registos relacionados

• Identification of common predictive markers of in vitro response to the MEK inhibitor selumetinib (AZD6244; ARRY-142886) in human breast cancer and non-small cell lung cancer cell lines
  Por: Garon, Edward B., et al.
  Publicado em: (2010)
• KRAS mutational subtype and copy number predict in vitro response of human pancreatic cancer cell lines to MEK inhibition
  Por: Hamidi, H, et al.
  Publicado em: (2014)
• PD 0332991, a selective cyclin D kinase 4/6 inhibitor, preferentially inhibits proliferation of luminal estrogen receptor-positive human breast cancer cell lines in vitro
  Por: Finn, Richard S, et al.
  Publicado em: (2009)
• Histone signature of metanephric mesenchyme cell lines
  Por: McLaughlin, Nathan, et al.
  Publicado em: (2013)
• A high-risk signature for patients with multiple myeloma established from the molecular classification of human myeloma cell lines
  Por: Moreaux, Jérôme, et al.
  Publicado em: (2011)